Variations of chromosomes 2 and 3 gene expression profiles among pulmonary telocytes, pneumocytes, airway cells, mesenchymal stem cells and lymphocytes

Minghuan Zheng, Xiaoru Sun, Miaomiao Zhang, Mengjia Qian, Yonghua Zheng, Meiyi Li, Sanda Maria Creţoiu, Chengshui Chen, Luonan Chen, Dragoş Crețoiu, Laurenţiu M. Popescu, Hao Fang, Xiangdong WangJournal of Cellular and Molecular Medicine 2014 · DOI

TL;DR

This study delves into the unique gene expression profiles of pulmonary telocytes (TCs) on chromosomes 2 and 3, comparing them to other lung-related cell types. The findings reveal specific gene patterns in TCs that suggest roles in tissue repair, inflammation modulation, and potentially lung cancer development and fibrosis.

What Problem Does This Paper Address?

Telocytes (TCs) are a recently identified cell type characterized by their exceptionally long cellular extensions called telopodes. While their presence has been noted across various tissues, their specific functions and molecular signatures, particularly in the lung, remain incompletely understood. Previous research had explored TC-specific gene patterns on chromosome 1, but a comprehensive understanding of their genetic makeup on other chromosomes, especially in the context of lung health and disease, was lacking. This paper aims to fill that gap by investigating the gene expression profiles of pulmonary TCs on chromosomes 2 and 3 and comparing them to a panel of relevant lung and immune cells.

Methods

The researchers employed a DNA microarray approach to analyze gene expression. Pulmonary telocytes were isolated and cultured from mouse lungs. RNA was extracted, labeled, and hybridized to a microarray chip containing probes for a vast number of mouse genes. This allowed for the quantification of gene expression levels in TCs.

To identify differentially expressed genes, the gene expression data from TCs was compared against data from several other cell types:

  • Mesenchymal stem cells (MSCs)
  • Fibroblasts (Fbs)
  • Alveolar type II cells (ATII)
  • Airway basal cells (ABCs)
  • Proximal airway cells (PACS)
  • CD8+ T cells from bronchial lymph nodes (T-BL)
  • CD8+ T cells from lungs (T-L)

Bioinformatics tools were then used to analyze the microarray data, identify genes that were significantly up- or down-regulated in TCs compared to the other cell types, and explore potential functional associations and gene networks.

Datasets

The study utilized gene expression data from the NCBI Gene Expression Omnibus (GEO) database. Specifically, they accessed data from:

  • GSE6846
  • GSE27379
  • GSE28651

In addition to these publicly available datasets, they also incorporated gene expression data from their own previous study on mouse pulmonary TCs, fibroblasts, and MSCs. The microarray used in this study covered approximately 39,000+ mouse genes and transcripts.

Key Insights and Ideas

  • TCs have a distinct genetic fingerprint: The study confirms that TCs possess unique gene expression patterns on chromosomes 2 and 3, setting them apart from other lung and immune cells. This reinforces their identity as a specialized cell type.
  • Myl9 overexpression points to injury and aging: The significant overexpression of the Myl9 gene in TCs is a key finding. Given Myl9's known role in cell adhesion, migration, and division, and its association with tissue injury and aging, this suggests TCs might play a role in lung repair and the aging process.
  • Pltp downregulation hints at anti-inflammatory roles: The downregulation of Pltp in TCs is interesting because Pltp is involved in lipid metabolism and immune modulation, and its high expression is linked to lung inflammation. This suggests TCs might contribute to reducing inflammation in the lungs.
  • Chromosome 3 genes link to cancer and fibrosis: The overexpression of genes like Sh3glb1, Tm4sf1, and Csf1 on chromosome 3 in TCs is associated with tumor promotion in lung cancer. Conversely, the downregulation of Pde5a is implicated in pulmonary fibrosis and interstitial lung diseases, suggesting a complex role for TCs in these conditions.
  • Hierarchical clustering reveals TCs' unique position: The hierarchical clustering analysis clearly shows that TCs cluster separately from other cell types, underscoring their distinct molecular profile.

Key Results

  • Chromosome 2:
    • 26 genes were overexpressed in TCs compared to other cells.
  • 80 genes were down-regulated in TCs compared to other cells.
  • Myl9 was significantly overexpressed (>4-fold) in TCs.
  • Genes like Pltp, Gzf1, Polr1b, Tasp1, Zbtb34, and Zfp120 were notably down-expressed.
  • Chromosome 3:
    • 13 genes were up-regulated in TCs compared to other cells.
  • 59 genes were down-regulated in TCs compared to other cells.
  • Sh3glb1, Tm4sf1, and Csf1 were overexpressed in TCs.
  • Pde5a was among the genes significantly down-expressed.

Limitations and Future Work

  • Mouse model: The study was conducted in mice, and while mouse and human genomes are largely conserved, direct translation of findings to human TCs requires further validation.
  • Functional validation: While gene expression patterns suggest potential roles, direct experimental validation of these functions (e.g., in cell culture or animal models) is needed to confirm the proposed roles of these genes in TCs.
  • Mechanistic understanding: The precise mechanisms by which these differentially expressed genes in TCs influence lung injury, aging, inflammation, cancer, and fibrosis are not fully elucidated and warrant further investigation.
  • Therapeutic potential: The authors suggest that the identified gene signatures, particularly the downregulation of Pde5a, might hold therapeutic potential for conditions like pulmonary fibrosis, which is a promising avenue for future research.

Summary updated

Abstract

Telocytes (TCs) were identified as a distinct cellular type of the interstitial tissue and defined as cells with extremely long telopodes (Tps). Our previous data demonstrated patterns of mouse TC-specific gene profiles on chromosome 1. The present study focuses on the identification of characters and patterns of TC-specific or TC-dominated gene expression profiles in chromosome 2 and 3, the network of principle genes and potential functional association. We compared gene expression profiles of pulmonary TCs, mesenchymal stem cells, fibroblasts, alveolar type II cells, airway basal cells, proximal airway cells, CD8(+) T cells from bronchial lymph nodes (T-BL), and CD8(+) T cells from lungs (T-LL). We identified that 26 or 80 genes of TCs in chromosome 2 and 13 or 59 genes of TCs up- or down-regulated in chromosome 3, as compared with other cells respectively. Obvious overexpression of Myl9 in chromosome 2 of TCs different from other cells, indicates that biological functions of TCs are mainly associated with tissue/organ injury and ageing, while down-expression of Pltp implies that TCs may be associated with inhibition or reduction of inflammation in the lung. Dominant overexpression of Sh3glb1, Tm4sf1 or Csf1 in chromosome 3 of TCs is mainly associated with tumour promotion in lung cancer, while most down-expression of Pde5 may be involved in the development of pulmonary fibrosis and other acute and chronic interstitial lung disease.
BibTeX
@article{zheng2014variations,
  author = {Minghuan Zheng and Xiaoru Sun and Miaomiao Zhang and Mengjia Qian and Yonghua Zheng and Meiyi Li and Sanda Maria Creţoiu and Chengshui Chen and Luonan Chen and Dragoş Crețoiu and Laurenţiu M. Popescu and Hao Fang and Xiangdong Wang},
  title = {{Variations of chromosomes 2 and 3 gene expression profiles among pulmonary telocytes, pneumocytes, airway cells, mesenchymal stem cells and lymphocytes}},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2014},
  doi = {10.1111/jcmm.12429},
}
Figure